The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine
Open accessAbstract
Objective: Mutations in KCNT1 have been implicated in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and epilepsy of infancy with migrating focal seizures (EIMFS). More recently, a whole exome sequencing study of epileptic encephalopathies identified an additional de novo mutation in 1 proband with EIMFS. We aim to investigate the electrophysiological and pharmacological characteristics of h KCNT1 mutations and examine developmental expression levels. Methods: Here we use a Xenopus laevis oocyte‐based automated 2‐electrode voltage clamp assay. The effects of quinidine (100 and 300μM) are also tested. Using quantitative reverse transcriptase polymerase chain reaction, the relative levels of mouse brain m Kcnt1 mRNA expression are determined. Results: We demonstrate that KCNT1 mutations implicated in epilepsy cause a marked increase in function. Importantly, there is a significant group difference in gain of function between mutations associated with ADNFLE and EIMFS. Finally, exposure to quinidine significantly reduces this gain of function for all mutations studied. Interpretation: These results establish direction for a targeted therapy and potentially exemplify a translational paradigm for in vitro studies informing novel therapies in a neuropsychiatric disease. Ann Neurol 2014;75:581–590
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
Self-citationHellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Jasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs
Liman, E. R., Tytgat, J., & Hess, P. (1992) · Neuron · doi:10.1016/0896-6273(92)90239-a · Cited by 1,084
Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes
Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., & Goldstein, D. B. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003709 · Cited by 901
Self-citationCalcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder
Du, W., Bautista, J. F., Yang, H., Diez-Sampedro, A., You, S.-A., Wang, L., Kotagal, P., Lüders, H. O., Shi, J., Cui, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1585 · Cited by 574
Barcia, G., Fleming, M. R., Deligniere, A., Gazula, V.-R., Brown, M. R., Langouet, M., Chen, H., Kronengold, J., Abhyankar, A., Cilio, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.2441 · Cited by 525 · cited 5×
“We also sought to verify, using human clones, the earlier rodent Kcnt1 functional reports of the EIMFS-associated mutations (R428Q and A934T).(6,8) In addition, we assessed the effects of quinidine on human KCNT1 wildtype (WT) and mutant channels.”
BackgroundResultInfluential
Cited by
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Self-citationThe genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
Self-citationDrug development in the era of precision medicine
Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493
Self-citationSymonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios
Zhu, X., Petrovski, S., Xie, P., Ruzzo, E. K., Lu, Y.-F., McSweeney, K. M., Ben-Zeev, B., Nissenkorn, A., Anikster, Y., Oz-Levi, D., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.191 · Cited by 342
Self-citationIon Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
Self-citationDefinition and diagnostic criteria of sleep-related hypermotor epilepsy
Tinuper, P., Bisulli, F., Cross, J. H., Hesdorffer, D., Kahane, P., Nobili, L., Provini, F., Scheffer, I. E., Tassi, L., Vignatelli, L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002666 · Cited by 306
Self-citationManford, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8394-2 · Cited by 299
The hidden genetics of epilepsy—a clinically important new paradigm
Thomas, R. H., & Berkovic, S. F. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.62 · Cited by 297
Self-citationTargeted treatment of migrating partial seizures of infancy with quinidine
Bearden, D., Strong, A., Ehnot, J., DiGiovine, M., Dlugos, D., & Goldberg, E. M. (2014) · Annals of Neurology · doi:10.1002/ana.24229 · Cited by 258
Self-citationMiceli, F., Soldovieri, M. V., Ambrosino, P., De Maria, M., Migliore, M., Migliore, R., & Taglialatela, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4423-14.2015 · Cited by 191
“…KCNT1 mutations occurring in malignant migrating partial seizures of infancy (Barcia et al., 2012); in KCNT1 mutants, treatment with quinidine restored normal channel function, highlighting novel therapeutic strategies for malignant migrating partial seizures of infancy (Milligan et al., 2014).”
BackgroundQuraishi, I. H., Stern, S., Mangan, K. P., Zhang, Y., Ali, S. R., Mercier, M. R., Marchetto, M. C., McLachlan, M. J., Jones, E. M., Gage, F. H., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1628-18.2019 · Cited by 103
Antisense oligonucleotide therapy for KCNT1 encephalopathy
Burbano, L. E., Li, M., Jancovski, N., Jafar-Nejad, P., Richards, K., Sedo, A., Soriano, A., Rollo, B., Jia, L., Gazina, E. V., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146090 · Cited by 80
“Functional studies have shown that KCNT1 pathogenic variants associated with epilepsy result in an overall gain-of-function effect on the channel activity, increasing the current up to 22-fold compared with the wild-type channel (6, 11, 17).”
Self-citationGertler, T. S., Cherian, S., DeKeyser, J.-M., Kearney, J. A., & George, A. L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105713 · Cited by 36
Metadata
- Authors
- Milligan, C. J., Li, M., Gazina, E. V., Heron, S. E., Nair, U., Trager, C., Reid, C. A., Venkat, A., Younkin, D. P., Dlugos, D. J., Petrovski, S., Goldstein, D. B., Dibbens, L. M., Scheffer, I. E., Berkovic, S. F., & Petrou, S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2014-04
- Volume
- 75
- Issue
- 4
- Pages
- 581-590
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2147817553
- Cited by
- 290
- References
- 34
- FWCI
- 20.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.